BHI acts as a bridge between early-stage life science companies and the broader ecosystem, helping them navigate the path from concept to commercialization.
In Conversation
With robust infrastructure, a strong talent pipeline, and a thriving collaborative ecosystem, the region is primed to support and drive the future of the life sciences…
We have deliberately pursued a value engineering approach, combining cost-effective manufacturing with uncompromising quality specifications.
Focusing on the generic and biosimilar market could make us a more secure, healthier nation.
I am confident that the foundations of our strong performance, clear strategic path, and honest leadership, position us to become one of Europe’s leading API manufacturers.
I want the word "pharmacist" to bring to mind not just a bottle of pills, but a caring healthcare professional who plays a vital role in…
Our role is to ensure we continue to be a catalyst for innovation rather than a source of additional barriers.
Our ambition at Vivatum is to modernise the delivery of peritoneal dialysis by integrating intelligent software with user-friendly hardware.
We exist to serve patients for whom no other options are available. That purpose is what drives us, and what defines the way we do business.
MoonLake represents a deliberate challenge to conventional biotech wisdom across multiple dimensions.
Digital pathology creates unprecedented opportunities for AI in cancer care.
Technologies enabling oral biologics development will become increasingly valuable as pharmaceutical companies recognize the commercial imperative for accessible, cost-effective alternatives to current injectable therapies.
